These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 34994964

  • 1. Tumor load rather than contrast enhancement is associated with the visual function of children and adolescents with optic pathway glioma - a retrospective Magnetic Resonance Imaging study.
    Kilian A, Aigner A, Simon M, Salchow DJ, Potratz C, Thomale UW, Hernáiz Driever P, Tietze A.
    J Neurooncol; 2022 Feb; 156(3):589-597. PubMed ID: 34994964
    [Abstract] [Full Text] [Related]

  • 2. The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis.
    Kotch C, Si SJ, Desai K, Caminada P, Lo Russo FM, Li Y, Liu GT, Avery RA, Fisher MJ.
    J Neurooncol; 2023 Sep; 164(3):741-747. PubMed ID: 37803102
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1.
    Sellmer L, Farschtschi S, Marangoni M, Heran MKS, Birch P, Wenzel R, Mautner VF, Friedman JM.
    Orphanet J Rare Dis; 2018 Apr 23; 13(1):62. PubMed ID: 29685181
    [Abstract] [Full Text] [Related]

  • 6. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More.
    Kinori M, Armarnik S, Listernick R, Charrow J, Zeid JL.
    Am J Ophthalmol; 2021 Jan 23; 221():91-96. PubMed ID: 32283094
    [Abstract] [Full Text] [Related]

  • 7. Quantitative MRI demonstrates abnormalities of the third ventricle subventricular zone in neurofibromatosis type-1 and sporadic paediatric optic pathway glioma.
    Boonzaier NR, Hales PW, D'Arco F, Walters BC, Kaur R, Mankad K, Cooper J, Liasis A, Smith V, O'Hare P, Hargrave D, Clark CA.
    Neuroimage Clin; 2020 Jan 23; 28():102447. PubMed ID: 33038669
    [Abstract] [Full Text] [Related]

  • 8. Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study.
    Henning AM, Handrup MM, Kjeldsen SM, Larsen DA, Ejerskov C.
    Orphanet J Rare Dis; 2021 Nov 22; 16(1):489. PubMed ID: 34809690
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic performance of an unenhanced MRI exam for tumor follow-up of the optic pathway gliomas in children.
    Marsault P, Ducassou S, Menut F, Bessou P, Havez-Enjolras M, Chateil JF.
    Neuroradiology; 2019 Jun 22; 61(6):711-720. PubMed ID: 30904949
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Automatic Visual Acuity Loss Prediction in Children with Optic Pathway Gliomas using Magnetic Resonance Imaging.
    Jiang Z, Parida A, Anwar SM, Tang Y, Roth HR, Fisher MJ, Packer RJ, Avery RA, Linguraru MG.
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul 22; 2023():1-5. PubMed ID: 38083430
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S, Flaherty M, Billson F, North K.
    Ophthalmology; 2004 Mar 22; 111(3):568-77. PubMed ID: 15019338
    [Abstract] [Full Text] [Related]

  • 14. Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1.
    de Blank PM, Berman JI, Liu GT, Roberts TP, Fisher MJ.
    Neuro Oncol; 2013 Aug 22; 15(8):1088-95. PubMed ID: 23658320
    [Abstract] [Full Text] [Related]

  • 15. Retinal nerve fiber layer thickness in children with optic pathway gliomas.
    Avery RA, Liu GT, Fisher MJ, Quinn GE, Belasco JB, Phillips PC, Maguire MG, Balcer LJ.
    Am J Ophthalmol; 2011 Mar 22; 151(3):542-9.e2. PubMed ID: 21232732
    [Abstract] [Full Text] [Related]

  • 16. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L, Darvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC.
    J AAPOS; 2010 Apr 22; 14(2):155-8. PubMed ID: 20451859
    [Abstract] [Full Text] [Related]

  • 17. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.
    Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT.
    Neuro Oncol; 2012 Jun 22; 14(6):790-7. PubMed ID: 22474213
    [Abstract] [Full Text] [Related]

  • 18. Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1.
    Avery RA, Mansoor A, Idrees R, Biggs E, Alsharid MA, Packer RJ, Linguraru MG.
    Neurology; 2016 Jun 14; 86(24):2264-70. PubMed ID: 27170570
    [Abstract] [Full Text] [Related]

  • 19. The Utility of Early Brain MRI for Patients with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Long-Term Follow-Up in a Tertiary Referral Hospital.
    Rony C, Aharoni S, Halevy A.
    Neuropediatrics; 2022 Oct 14; 53(5):370-375. PubMed ID: 35381604
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.